Detailed Information on Publication Record
2023
CENA VÝBORU ČESKÉ PNEUMOLOGICKÉ A FTIZEOLOGICKÉ SPOLEČNOSTI ČLS JEP ZA 1. NEJLEPŠÍ PUBLIKOVANOU PRÁCI V KATEGORII PUBLIKACE S IMPAKT FAKTOREM POD 35 LET V ROCE 2022: Aminophylline Induces Two Types of Arrhythmic Events in Human Pluripotent Stem Cell–Derived Cardiomyocytes
KLIMOVIČ, Šimon, Martin ŠČUREK, Martin PEŠL, Deborah BECKEROVÁ, Šárka JELÍNKOVÁ et. al.Basic information
Original name
CENA VÝBORU ČESKÉ PNEUMOLOGICKÉ A FTIZEOLOGICKÉ SPOLEČNOSTI ČLS JEP ZA 1. NEJLEPŠÍ PUBLIKOVANOU PRÁCI V KATEGORII PUBLIKACE S IMPAKT FAKTOREM POD 35 LET V ROCE 2022: Aminophylline Induces Two Types of Arrhythmic Events in Human Pluripotent Stem Cell–Derived Cardiomyocytes
Authors
KLIMOVIČ, Šimon, Martin ŠČUREK, Martin PEŠL, Deborah BECKEROVÁ, Šárka JELÍNKOVÁ, Tomáš URBAN, Daniil KABANOV, Zdeněk STÁREK, Markéta BÉBAROVÁ, Jan PŘIBYL, Vladimír ROTREKL and Kristián BRAT
Edition
2023
Publisher
VÝBOR ČESKÉ PNEUMOLOGICKÉ A FTIZEOLOGICKÉ SPOLEČNOSTI ČLS JEP
Other information
Language
English
Type of outcome
Ocenění vědecké a umělecké činnosti
Field of Study
30402 Technologies involving the manipulation of cells, tissues, organs or the whole organism
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Organization unit
Central European Institute of Technology
Keywords in English
aminophylline; IPSC; hESC; cardiomyocytes; drug cardiotoxicity; atomic force microscopy; arrhythmogenic effects; methylxanthines
Tags
International impact, Reviewed
Změněno: 15/11/2023 08:21, MUDr. Martin Pešl, Ph.D.
Abstract
V originále
Cardiac side effects of some pulmonary drugs are observed in clinical practice. Aminophylline, a methylxanthine bronchodilator with documented proarrhythmic action, may serve as an example. Data on the action of aminophylline on cardiac cell electrophysiology and contractility are not available. Hence, this study was focused on the analysis of changes in the beat rate and contraction force of human pluripotent stem cell–derived cardiomyocytes (hPSC-CMs) and HL-1 cardiomyocytes in the presence of increasing concentrations of aminophylline (10 µM–10 mM in hPSC-CM and 8–512 µM in HL-1 cardiomyocytes). Basic biomedical parameters, namely, the beat rate (BR) and contraction force, were assessed in hPSC-CMs using an atomic force microscope (AFM). The beat rate changes under aminophylline were also examined on the HL-1 cardiac muscle cell line via a multielectrode array (MEA). Additionally, calcium imaging was used to evaluate the effect of aminophylline on intracellular Ca2+ dynamics in HL-1 cardiomyocytes. The BR was significantly increased after the application of aminophylline both in hPSC-CMs (with 10 mM aminophylline) and in HL-1 cardiomyocytes (with 256 and 512 µM aminophylline) in comparison with controls. A significant increase in the contraction force was also observed in hPSC-CMs with 10 µM aminophylline (a similar trend was visible at higher concentrations as well). We demonstrated that all aminophylline concentrations significantly increased the frequency of rhythm irregularities (extreme interbeat intervals) both in hPSC-CMs and HL-1 cells. The occurrence of the calcium sparks in HL-1 cardiomyocytes was significantly increased with the presence of 512 µM aminophylline. We conclude that the observed aberrant cardiomyocyte response to aminophylline suggests an arrhythmogenic potential of the drug. The acquired data represent a missing link between the arrhythmic events related to the aminophylline/theophylline treatment in clinical practice and describe cellular mechanisms of methylxanthine arrhythmogenesis. An AFM combined with hPSC-CMs may serve as a robust platform for direct drug effect screening.
Links
EF19_073/0016943, research and development project |
| ||
LM2018127, research and development project |
| ||
MUNI/A/1133/2021, interní kód MU |
| ||
MUNI/A/1246/2020, interní kód MU |
| ||
MUNI/A/1418/2021, interní kód MU |
| ||
MUNI/A/1700/2020, interní kód MU |
| ||
MUNI/IGA/1428/2020, interní kód MU |
| ||
NU20-06-00156, research and development project |
|